Seroprevalence of bovine vaccinia in cows and its correlation with the productive profile of affected farms in Distrito Federal, Brazil.

Bovine vaccinia (BV) is an infectious disease caused by Vaccinia virus (VACV) characterized by vesicular and exanthematic lesions, mainly in cattle. Although BV has been described in some Brazilian regions in the last decades, official information regarding the current prevalence in bovine herds of Midwestern Brazil is lacking. Thus, the current study aimed to estimate the seroprevalence and risk factors associated with BV in cattle in the Distrito Federal (DF), Brazil. Sera of 312 cows of 64 herds were tested by virus-neutralizing test for VACV antibodies. Herd and animal seroprevalence were estimated to be 33.3% (CI 95%: 18.2-48.3%) and 10.6% (CI 95%: 1.0-20.2%), respectively. Seropositive cows were detected in dairy, beef, and mixed-purpose farms. The results of an epidemiological questionnaire showed that no risk factor analyzed was positively associated with seropositivity to VACV. There was no significant association between type of milking (manual/mechanic) and seropositivity to VACV; however, most seropositive cows were present in farms with high daily milk production and high number of lactating and adult cows. Our results indicate that VACV circulates in many regions of DF with considerable prevalence in dairy cows. Control measures to restrict VACV circulation and consequences of the infection may be advisable.

Large-scale study of herd-level risk factors for bovine brucellosis in Brazil.

Bovine brucellosis is an important zoonosis caused by Brucella abortus that negatively impacts livestock productivity. In 2001, Brazil launched a new national program aimed at eradicating animal brucellosis that included large-scale studies of the prevalence and risk factors to support strategic decision-making. These studies were implemented by the animal health authorities and were underpinned by the scientific coordination of the University of São Paulo and the University of Brasília. The state-level results were published and revealed important differences in herd prevalence among regions. The risk factors varied across states and did not clearly explain the observed spatial disease spread. This study used a consolidated herd-level database of 14 states and 17,100 herds, from the prevalence surveys' data, to gain insights into herd profiles and cattle production practices that might be associated with the risk of brucellosis. At the time of data collection, the study area comprised just over 56 million bovine females aged over 24 months and approximately 1.8 million herds. After an exploratory univariable analysis, all factors with p≤0.20 were included in a multiple logistic regression model, using the design-based method in order to take herd sampling weights into account. The number of females in the herd markedly increased the risk of infection; compared with smaller herds (less than 30 females), the odds ratio was 3.42 [CI 95% 2.98-3.91] for herds with 31 to 100 females, 5.68 [4.92-6.55] for herds with 101 to 400 females, and 13.14 [10.94-15.78] for herds with more than 400 females. The risk was higher for extensive cattle production farms (OR=1.23 [1.07-1.42]) and for farms that purchased replacement stock from cattle traders (OR=1.27 [1.08-1.47]) or directly from other farms (OR=1.19 [1.07-1.32]). The exclusive use of artificial insemination (OR=0.57 [0.4-0.81]) and regular veterinary support (OR=0.68 [0.6-0.77]) appeared to be protective factors. These findings are consistent with the regional prevalence trends observed in the study and provide key guidance for the planning of the national effort to control and eradicate brucellosis. High vaccination coverage of heifers is recommended, especially when targeted to areas where large-scale extensive cattle production predominates. The smaller, more intensive herds, are good candidates for disease accreditation schemes.